73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New prognostic biomarker identified in small cell lung cancer

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of
Study demonstrates antitumor action of substance present in Brazilian green propolis

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Experimental ovarian cancer diagnostic could lead to new precision oncology approach

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (
Researchers uncovers promising cancer target for liposarcoma

Researchers uncovers promising cancer target for liposarcoma

by National University of SingaporeCredit: CC0 Public DomainA study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of

Researchers uncovers promising cancer target for liposarcoma

by National University of SingaporeCredit: CC0 Public DomainA study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of
Scientists map the evolution of urinary tract cancer cells

Scientists map the evolution of urinary tract cancer cells

by Weill Cornell Medical CollegeImaging Mass Cytometry shows the immune-inflamed subtype of upper tract urothelial carcinoma at single-cell resolution. Red: tumor-expressed E-cadherin; Green: T-c

Scientists map the evolution of urinary tract cancer cells

by Weill Cornell Medical CollegeImaging Mass Cytometry shows the immune-inflamed subtype of upper tract urothelial carcinoma at single-cell resolution. Red: tumor-expressed E-cadherin; Green: T-c
'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '
Research highlights industry and regulatory perspectives on improving diversity in clinical trials

Research highlights industry and regulatory perspectives on improving diversity in clinical trials

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainClinical Cancer Researchpublished an article today outlining steps clinical trial sponsors can take to improve di

Research highlights industry and regulatory perspectives on improving diversity in clinical trials

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainClinical Cancer Researchpublished an article today outlining steps clinical trial sponsors can take to improve di
Researcher patents 'roach motel' for cancer

Researcher patents 'roach motel' for cancer

by Louisa Kellie,University of Texas at ArlingtonA cancer trap. Credit: UTAThe University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts an

Researcher patents 'roach motel' for cancer

by Louisa Kellie,University of Texas at ArlingtonA cancer trap. Credit: UTAThe University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts an
Newly developed gene classifier identifies risk of pre-breast cancer progression

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil
Researchers discover the Achilles' heel of an aggressive brain cancer

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen

Researchers discover the Achilles' heel of an aggressive brain cancer

by University of HelsinkiGlioblastoma cells (red) are known to invade the brain (blue). Figure shows patient-derived glioblastoma in murine brain treated with saline (control). Credit: Laakkonen
Novel inherited variants may raise risk for Hodgkin lymphoma

Novel inherited variants may raise risk for Hodgkin lymphoma

Novel coding and noncoding gene variants have been identified that may increase the risk for developing Hodgkin lymphoma (HL), according to a study published online Aug. 20 inBlood.Jamie E. Fler

Novel inherited variants may raise risk for Hodgkin lymphoma

Novel coding and noncoding gene variants have been identified that may increase the risk for developing Hodgkin lymphoma (HL), according to a study published online Aug. 20 inBlood.Jamie E. Fler